PortalPublikationenInternational, Multicenter Standardization of Acute Graft-ve...

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

Standard

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium. / Harris, Andrew C; Young, Rachel; Devine, Steven; Hogan, William J; Ayuketang, Francis Ayuk; Bunworasate, Udomsak; Chanswangphuwana, Chantiya; Efebera, Yvonne A; Holler, Ernst; Litzow, Mark; Ordemann, Rainer; Qayed, Muna; Renteria, Anne S; Reshef, Ran; Wölfl, Matthias; Chen, Yi-Bin; Goldstein, Steven; Jagasia, Madan; Locatelli, Franco; Mielke, Stephan; Porter, David; Schechter, Tal; Shekhovtsova, Zhanna; Ferrara, James L M; Levine, John E.

in: BIOL BLOOD MARROW TR, Jahrgang 22, Nr. 1, 01.2016, S. 4-10.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Harris, AC, Young, R, Devine, S, Hogan, WJ, Ayuketang, FA, Bunworasate, U, Chanswangphuwana, C, Efebera, YA, Holler, E, Litzow, M, Ordemann, R, Qayed, M, Renteria, AS, Reshef, R, Wölfl, M, Chen, Y-B, Goldstein, S, Jagasia, M, Locatelli, F, Mielke, S, Porter, D, Schechter, T, Shekhovtsova, Z, Ferrara, JLM & Levine, JE 2016, 'International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium', BIOL BLOOD MARROW TR, Jg. 22, Nr. 1, S. 4-10. https://doi.org/10.1016/j.bbmt.2015.09.001

APA

Harris, A. C., Young, R., Devine, S., Hogan, W. J., Ayuketang, F. A., Bunworasate, U., Chanswangphuwana, C., Efebera, Y. A., Holler, E., Litzow, M., Ordemann, R., Qayed, M., Renteria, A. S., Reshef, R., Wölfl, M., Chen, Y-B., Goldstein, S., Jagasia, M., Locatelli, F., ... Levine, J. E. (2016). International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium. BIOL BLOOD MARROW TR, 22(1), 4-10. https://doi.org/10.1016/j.bbmt.2015.09.001

Vancouver

Harris AC, Young R, Devine S, Hogan WJ, Ayuketang FA, Bunworasate U et al. International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium. BIOL BLOOD MARROW TR. 2016 Jan;22(1):4-10. https://doi.org/10.1016/j.bbmt.2015.09.001

Bibtex

@article{e6cdd3bb94494f19afd8771a6b89d06d,
title = "International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium",
abstract = "Acute graft-versus-host disease (GVHD) remains a leading cause of morbidity and nonrelapse mortality after allogeneic hematopoietic cell transplantation. The clinical staging of GVHD varies greatly between transplant centers and is frequently not agreed on by independent reviewers. The lack of standardized approaches to handle common sources of discrepancy in GVHD grading likely contributes to why promising GVHD treatments reported from single centers have failed to show benefit in randomized multicenter clinical trials. We developed guidelines through international expert consensus opinion to standardize the diagnosis and clinical staging of GVHD for use in a large international GVHD research consortium. During the first year of use, the guidance followed discussion of complex clinical phenotypes by experienced transplant physicians and data managers. These guidelines increase the uniformity of GVHD symptom capture, which may improve the reproducibility of GVHD clinical trials after further prospective validation.",
author = "Harris, {Andrew C} and Rachel Young and Steven Devine and Hogan, {William J} and Ayuketang, {Francis Ayuk} and Udomsak Bunworasate and Chantiya Chanswangphuwana and Efebera, {Yvonne A} and Ernst Holler and Mark Litzow and Rainer Ordemann and Muna Qayed and Renteria, {Anne S} and Ran Reshef and Matthias W{\"o}lfl and Yi-Bin Chen and Steven Goldstein and Madan Jagasia and Franco Locatelli and Stephan Mielke and David Porter and Tal Schechter and Zhanna Shekhovtsova and Ferrara, {James L M} and Levine, {John E}",
note = "Copyright {\textcopyright} 2016 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.",
year = "2016",
month = jan,
doi = "10.1016/j.bbmt.2015.09.001",
language = "English",
volume = "22",
pages = "4--10",
journal = "BIOL BLOOD MARROW TR",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

AU - Harris, Andrew C

AU - Young, Rachel

AU - Devine, Steven

AU - Hogan, William J

AU - Ayuketang, Francis Ayuk

AU - Bunworasate, Udomsak

AU - Chanswangphuwana, Chantiya

AU - Efebera, Yvonne A

AU - Holler, Ernst

AU - Litzow, Mark

AU - Ordemann, Rainer

AU - Qayed, Muna

AU - Renteria, Anne S

AU - Reshef, Ran

AU - Wölfl, Matthias

AU - Chen, Yi-Bin

AU - Goldstein, Steven

AU - Jagasia, Madan

AU - Locatelli, Franco

AU - Mielke, Stephan

AU - Porter, David

AU - Schechter, Tal

AU - Shekhovtsova, Zhanna

AU - Ferrara, James L M

AU - Levine, John E

N1 - Copyright © 2016 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

PY - 2016/1

Y1 - 2016/1

N2 - Acute graft-versus-host disease (GVHD) remains a leading cause of morbidity and nonrelapse mortality after allogeneic hematopoietic cell transplantation. The clinical staging of GVHD varies greatly between transplant centers and is frequently not agreed on by independent reviewers. The lack of standardized approaches to handle common sources of discrepancy in GVHD grading likely contributes to why promising GVHD treatments reported from single centers have failed to show benefit in randomized multicenter clinical trials. We developed guidelines through international expert consensus opinion to standardize the diagnosis and clinical staging of GVHD for use in a large international GVHD research consortium. During the first year of use, the guidance followed discussion of complex clinical phenotypes by experienced transplant physicians and data managers. These guidelines increase the uniformity of GVHD symptom capture, which may improve the reproducibility of GVHD clinical trials after further prospective validation.

AB - Acute graft-versus-host disease (GVHD) remains a leading cause of morbidity and nonrelapse mortality after allogeneic hematopoietic cell transplantation. The clinical staging of GVHD varies greatly between transplant centers and is frequently not agreed on by independent reviewers. The lack of standardized approaches to handle common sources of discrepancy in GVHD grading likely contributes to why promising GVHD treatments reported from single centers have failed to show benefit in randomized multicenter clinical trials. We developed guidelines through international expert consensus opinion to standardize the diagnosis and clinical staging of GVHD for use in a large international GVHD research consortium. During the first year of use, the guidance followed discussion of complex clinical phenotypes by experienced transplant physicians and data managers. These guidelines increase the uniformity of GVHD symptom capture, which may improve the reproducibility of GVHD clinical trials after further prospective validation.

U2 - 10.1016/j.bbmt.2015.09.001

DO - 10.1016/j.bbmt.2015.09.001

M3 - SCORING: Journal article

C2 - 26386318

VL - 22

SP - 4

EP - 10

JO - BIOL BLOOD MARROW TR

JF - BIOL BLOOD MARROW TR

SN - 1083-8791

IS - 1

ER -